(Q71807517)

English

The Circulatory Regulation of TPA and UPA Secretion, Clearance, and Inhibition During Exercise and During the Infusion of Isoproterenol and Phenylephrine

scientific article published on November 15, 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7586269%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

The circulatory regulation of TPA and UPA secretion, clearance, and inhibition during exercise and during the infusion of isoproterenol and phenylephrine (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7586269%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

The Circulatory Regulation of TPA and UPA Secretion, Clearance, and Inhibition During Exercise and During the Infusion of Isoproterenol and Phenylephrine (English)

1 reference

10.1161/01.CIR.92.10.2984

https://api.crossref.org/works/10.1161/01.CIR.92.10.2984

25 May 2024

author name string

W. L. Chandler

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586269

25 May 2024

W. C. Levy

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586269

25 May 2024

J. R. Stratton

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586269

25 May 2024

language of work or name

0 references

publication date

1 November 1995

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7586269%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

15 November 1995

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7586269

25 May 2024

full work available at URL

https://www.ahajournals.org/doi/full/10.1161/01.CIR.92.10.2984

1 reference

10.1161/01.CIR.92.10.2984

https://api.crossref.org/works/10.1161/01.CIR.92.10.2984

25 May 2024

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7586269%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

92

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7586269%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7586269%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

2984-2994

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7586269%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1

1 reference

10.1161/01.CIR.92.10.2984

https://api.crossref.org/works/10.1161/01.CIR.92.10.2984

25 May 2024

Endogenous tissue-type plasminogen activator and risk of myocardial infarction

2

1 reference

10.1161/01.CIR.92.10.2984

https://api.crossref.org/works/10.1161/01.CIR.92.10.2984

25 May 2024

A depression of active tissue plasminogen activator in plasma characterizes patients with unstable angina pectoris who develop myocardial infarction

3

1 reference

10.1161/01.CIR.92.10.2984

https://api.crossref.org/works/10.1161/01.CIR.92.10.2984

25 May 2024

Pharmacological Reviews

11

33

213

publication date

1982

1 reference

10.1161/01.CIR.92.10.2984

https://api.crossref.org/works/10.1161/01.CIR.92.10.2984

25 May 2024

Adrenergic mechanisms in the systemic plasminogen active response to adrenaline in man

14

1 reference

10.1161/01.CIR.92.10.2984

https://api.crossref.org/works/10.1161/01.CIR.92.10.2984

25 May 2024

The fibrinolytic response of man to vasoactive drugs measured in arterial blood

15

1 reference

10.1161/01.CIR.92.10.2984

https://api.crossref.org/works/10.1161/01.CIR.92.10.2984

25 May 2024

Pro-urokinase: physiochemical properties and promotion of its fibrinolytic activity by urokinase and by tissue plasminogen activator with which it has a complementary mechanism of action

16

1 reference

10.1161/01.CIR.92.10.2984

https://api.crossref.org/works/10.1161/01.CIR.92.10.2984

25 May 2024

Coronary thrombolysis with human single-chain, urokinase-type plasminogen activator (pro-urokinase) in patients with acute myocardial infarction

21

1 reference

10.1161/01.CIR.92.10.2984

https://api.crossref.org/works/10.1161/01.CIR.92.10.2984

25 May 2024

Fibrinolytic response during exercise and epinephrine infusion in the same subjects

28

1 reference

10.1161/01.CIR.92.10.2984

https://api.crossref.org/works/10.1161/01.CIR.92.10.2984

25 May 2024

Regulation of the Acute Release of Tissue‐type Plasminogen Activator from the Endothelium by Coagulation Activation Products

30

1 reference

10.1161/01.CIR.92.10.2984

https://api.crossref.org/works/10.1161/01.CIR.92.10.2984

25 May 2024

Measurement of tPA and tPA-PAI-1 complexes by ELISA, using monoclonal antibodies: clinical relevance

39

1 reference

10.1161/01.CIR.92.10.2984

https://api.crossref.org/works/10.1161/01.CIR.92.10.2984

25 May 2024

α- and β-receptor blockade of isoproterenol- and norepinephrine-induced effects on regional blood flow and blood flow acceleration

46

1 reference

10.1161/01.CIR.92.10.2984

https://api.crossref.org/works/10.1161/01.CIR.92.10.2984

25 May 2024

Yale Journal of Biology and Medicine

47

52

99

publication date

1979

1 reference

10.1161/01.CIR.92.10.2984

https://api.crossref.org/works/10.1161/01.CIR.92.10.2984

25 May 2024

Characterization of the beta-adrenoreceptors which mediate the isoprenaline-induced changes in finger tremor and cardiovascular function in man.

48

1 reference

10.1161/01.CIR.92.10.2984

https://api.crossref.org/works/10.1161/01.CIR.92.10.2984

25 May 2024

Responses of forearm blood flow to graded leg exercise in man

50

1 reference

10.1161/01.CIR.92.10.2984

https://api.crossref.org/works/10.1161/01.CIR.92.10.2984

25 May 2024

Correlations between t-PA and PAI-1 antigen and activity and t-PA/PAI-1 complexes in plasma of control subjects and of patients with increased t-PA or PAI-1 levels.

57

1 reference

10.1161/01.CIR.92.10.2984

https://api.crossref.org/works/10.1161/01.CIR.92.10.2984

25 May 2024

Hepatic synthesis and clearance of components of the fibrinolytic system in healthy volunteers and in patients with different stages of liver cirrhosis

58

1 reference

10.1161/01.CIR.92.10.2984

https://api.crossref.org/works/10.1161/01.CIR.92.10.2984

25 May 2024

Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response

60

1 reference

10.1161/01.CIR.92.10.2984

https://api.crossref.org/works/10.1161/01.CIR.92.10.2984

25 May 2024

PAI-1 Synthesis in the Human Hepatoma Cell Line Hep G2 Is Increased by Cytokines - Evidence that the Liver Contributes to Acute Phase Behaviour of PAI-1

66

1 reference

10.1161/01.CIR.92.10.2984

https://api.crossref.org/works/10.1161/01.CIR.92.10.2984

25 May 2024

Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke

67

1 reference

10.1161/01.CIR.92.10.2984

https://api.crossref.org/works/10.1161/01.CIR.92.10.2984

25 May 2024

Insulin, cortisol and catecholamines do not regulate circadian variations in fibrinolytic activity

68

1 reference

10.1161/01.CIR.92.10.2984

https://api.crossref.org/works/10.1161/01.CIR.92.10.2984

25 May 2024

Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator

70

1 reference

10.1161/01.CIR.92.10.2984

https://api.crossref.org/works/10.1161/01.CIR.92.10.2984

25 May 2024

Enzymatic properties of the one- and two-chain form of tissue plasminogen activator

71

1 reference

10.1161/01.CIR.92.10.2984

https://api.crossref.org/works/10.1161/01.CIR.92.10.2984

25 May 2024

Laboratory evaluation of fibrinolysis in patients with a history of myocardial infarction

74

1 reference

10.1161/01.CIR.92.10.2984

https://api.crossref.org/works/10.1161/01.CIR.92.10.2984

25 May 2024

Muscle metabolism during exercise and heat stress in trained men: effect of acclimation

75

1 reference

10.1161/01.CIR.92.10.2984

https://api.crossref.org/works/10.1161/01.CIR.92.10.2984

25 May 2024

Identifiers

10.1161/01.CIR.92.10.2984

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7586269%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7586269%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71807517&oldid=2164435060"